Edgewise Therapeutics Inc. logo

EWTX

Edgewise Therapeutics Inc. · NASDAQ

Website
Market cap
$5.03B

Edgewise Therapeutics Inc. (EWTX) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 9 wire items for EWTX, including 4 press releases and news items, 2 SEC filings and 1 earnings update. The most recent was published Nov 10, 2026.

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.

EWTX rankings

Financial highlights

Full financials
Net income, TTM
$1.01B
Free cash flow, TTM
-$202.28M
Cash
$68.68M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks56+125%
2026-05-24: 02026-05-31: 52026-06-07: 02026-06-14: 82026-06-21: 02026-06-28: 42026-07-05: 12026-07-12: 52026-07-19: 02026-07-26: 02026-08-02: 42026-08-09: 82026-08-16: 52026-08-23: 12026-08-30: 12026-09-06: 02026-09-13: 02026-09-20: 12026-09-27: 22026-10-04: 12026-10-11: 12026-10-18: 02026-10-25: 02026-11-01: 62026-11-08: 32026-11-15: 0
2026-05-242026-11-15
Mix1690d
  • Other8(50%)
  • Earnings2(13%)
  • Insider2(13%)
  • SEC Filings2(13%)
  • Analyst1(6%)
  • 13D/G1(6%)
Activity · 52 weeks9657 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

EWTX FAQ

10 questions
  • What does Edgewise Therapeutics Inc. do?
    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
  • What is the latest news on EWTX?
    In the last 30 days Quantisnow tracked 9 wire items for EWTX: 4 press releases and news items, 2 SEC filings, 1 earnings update and 1 13D/G filing. The most recent was published on November 10, 2026.
  • Is EWTX profitable?
    Yes. Edgewise Therapeutics Inc. earned $1.01B in net income for the twelve months ended Sep 30, 2026.
  • How much cash and debt does EWTX have?
    Edgewise Therapeutics Inc. reported $68.68M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does EWTX stock trade?
    Edgewise Therapeutics Inc. (EWTX) is listed on NASDAQ.
  • What sector and industry is EWTX in?
    Edgewise Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Edgewise Therapeutics Inc. go public?
    Edgewise Therapeutics Inc. (EWTX) completed its IPO in 2021.
  • What are analysts saying about EWTX?
    Across the last 8 analyst actions on Edgewise Therapeutics Inc., there were 0 upgrades and 1 downgrade. The most recent action was from William Blair: Outperform on 2026-10-16. Recent price targets range from $14.00 to $51.00.
  • What companies are similar to EWTX?
    Notable peers in the same industry include MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories). Compare EWTX side-by-side with any of them on Quantisnow.
  • How can I track EWTX on Quantisnow?
    Quantisnow aggregates Edgewise Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EWTX to receive live email and push alerts on every new disclosure.